Dosing for lisinopril
Pro Research Analysisby 
Searched over 200M research papers
Dosing for Lisinopril: Insights from Research Studies
Introduction to Lisinopril Dosing
Lisinopril is a widely used angiotensin-converting enzyme (ACE) inhibitor for treating hypertension and other cardiovascular conditions. Understanding the optimal dosing for different patient populations is crucial for maximizing therapeutic benefits while minimizing adverse effects.
Pediatric Hypertension: Lisinopril Dosing in Children
A study involving 115 hypertensive children aged 6 to 16 years explored the dose-response relationship and safety of lisinopril. Children weighing less than 50 kg were administered low (0.625 mg), middle (2.5 mg), and high (20 mg) doses, while those weighing 50 kg or more received low (1.25 mg), middle (5 mg), and high (40 mg) doses. The study found a clear dose-response relationship, with an initial dose of 0.07 mg/kg once daily effectively lowering blood pressure within two weeks. This indicates that lisinopril is both effective and well-tolerated in pediatric patients.
Essential Hypertension: Dose-Peak Effect Relationship
In adults with mild to moderate essential hypertension, a study evaluated the dose-peak effect relationship of lisinopril. Patients were administered doses of 2.5, 10, 20, or 80 mg daily. The results showed that 10 and 20 mg doses produced similar peak antihypertensive effects, which were greater than the 2.5 mg dose but less than the 80 mg dose. This suggests that an initial dose of 20 mg does not pose a greater risk of first-dose symptomatic hypotension compared to a 10 mg dose.
Renoprotection in Diabetic Nephropathy
For type 1 diabetic patients with diabetic nephropathy, a study compared the renoprotective effects of lisinopril at doses of 20, 40, and 60 mg daily. The findings indicated that 40 mg provided additional reductions in urinary albumin excretion rate (UAER) and blood pressure compared to 20 mg, while 60 mg did not offer further benefits. Therefore, 40 mg daily is considered optimal for renoprotection in these patients.
Acute Ischemic Stroke: Early Intervention
In hypertensive patients with acute ischemic stroke, initiating lisinopril within 24 hours at a dose of 5 mg, increased to 10 mg if necessary, was found to be effective in reducing blood pressure without significant adverse effects. This early intervention can be beneficial in managing hypertension post-stroke.
Twice-Daily vs. Once-Daily Dosing
A retrospective cohort study compared the efficacy of twice-daily versus once-daily dosing of lisinopril in hypertensive patients. The study found that twice-daily administration (20 mg twice daily) resulted in greater reductions in systolic and diastolic blood pressure compared to the same total daily dose administered once daily (40 mg once daily). This suggests that twice-daily dosing may be more effective for certain patients.
Pharmacokinetics in Pediatric Patients
A study on the pharmacokinetics of lisinopril in hypertensive children and adolescents highlighted the importance of adjusting doses based on body weight and estimated glomerular filtration rate (eGFR). The study recommended dose adjustments to account for these factors to optimize therapeutic outcomes.
Conclusion
Lisinopril is a versatile antihypertensive agent with a well-established dose-response relationship across various patient populations. For pediatric patients, an initial dose of 0.07 mg/kg once daily is effective. In adults, doses of 10 to 20 mg daily are generally effective for essential hypertension, while 40 mg daily is optimal for renoprotection in diabetic nephropathy. Early intervention with lisinopril post-stroke and twice-daily dosing may offer additional benefits in specific scenarios. Adjusting doses based on weight and kidney function is crucial for pediatric patients to ensure safety and efficacy.
Sources and full results
Most relevant research papers on this topic